| Insights into Elution of Anion Exchange Cartridges: Opening the Path toward Aliphatic 18F-Radiolabeling of Base-Sensitive Tracers K Bratteby, V Shalgunov, UM Battisti, IN Petersen, SL van den Broek, ... ACS pharmacology & translational science 4 (5), 1556-1566, 2021 | 28 | 2021 |
| Pretargeted imaging beyond the blood–brain barrier V Shalgunov, SL van den Broek, IV Andersen, RG Vázquez, NR Raval, ... RSC medicinal chemistry 14 (3), 444-453, 2023 | 18 | 2023 |
| Pretargeted imaging beyond the blood–brain barrier—utopia or feasible? S Lopes van den Broek, V Shalgunov, R García Vázquez, N Beschorner, ... Pharmaceuticals 15 (10), 1191, 2022 | 12 | 2022 |
| Transport of nanomedicines across the blood-brain barrier: Challenges and opportunities for imaging and therapy SL van den Broek, V Shalgunov, MM Herth Biomaterials advances 141, 213125, 2022 | 10 | 2022 |
| A nanobody recognizes a unique conserved epitope and potently neutralizes SARS-CoV-2 omicron variants N Modhiran, SM Lauer, AA Amarilla, P Hewins, SIL van den Broek, ... Iscience 26 (7), 107085, 2023 | 4 | 2023 |
| Bioorthogonal Click of Colloidal Gold Nanoparticles to Antibodies In vivo CBM Poulie, E Sporer, L Hvass, JT Jørgensen, PJ Kempen, ... Chemistry–A European Journal 28 (61), e202201847, 2022 | 4 | 2022 |
| Development of trans-cyclooctene modified antibodies for pretargeted imaging within the central nervous system SL van den Broek, V Shalgunov, D Sehlin, S Syvanen, M Herth Journal of Nuclear Medicine 61 (supplement 1), 196-196, 2020 | 3 | 2020 |
| Development of the First Tritiated Tetrazine: Facilitating Tritiation of Proteins NS Radjani Bidesi, UM Battisti, S Lopes van de Broek, V Shalgunov, ... ChemBioChem 23 (23), e202200539, 2022 | 2 | 2022 |
| The Alzheimer's disease 5xFAD mouse model is best suited to investigate pretargeted imaging approaches beyond the blood-brain barrier S Lopes van den Broek, D Sehlin, JV Andersen, BI Aldana, N Beschörner, ... Frontiers in Nuclear Medicine 2, 1001722, 2022 | 2 | 2022 |
| A convenient tritiation strategy for tetrazines N Bidesi, U Battisti, SL van den Broek, V Shalgunov, AM Dall, ... Nuclear Medicine and Biology 108, S90, 2022 | 1 | 2022 |
| Development of 18F-Labeled tetrazines for pretargeted imaging across the blood-brain barrier V Shalgunov, SL van den Broek, I Andersen, RG Vázquez, N Raval, ... Nuclear Medicine and Biology 108, S103-S104, 2022 | 1 | 2022 |
| Trans-cyclooctene modified antibodies for pretargeted imaging of amyloid-β SL van den Broek, V Shalgunov, G Knudsen, D Sehlin, S Syvaenen, ... Nuclear Medicine and Biology 108, S98-S99, 2022 | 1 | 2022 |
| Radiolabeled albumin through SN Ar of cysteines as a potential pretargeting theranostic agent NH Fischer, SIL van den Broek, MM Herth, F Diness RSC advances 12 (54), 35032-35036, 2022 | 1 | 2022 |
| Synthesis and evaluation of fluorine-18 labelled tetrazines as pre-targeting imaging agents for PET E Schlein, J Rokka, LR Odell, SL van den Broek, MM Herth, UM Battisti, ... EJNMMI radiopharmacy and chemistry 9 (1), 21, 2024 | | 2024 |
| Evaluation of F-537-Tetrazine in a model for brain pretargeting imaging. Comparison to N-(3-[18F] fluoro-5-(1, 2, 4, 5-tetrazin-3-yl) benzyl) propan-1-amine V Shalgunov, SL van den Broek, IV Andersen, NR Raval, G Schäfer, ... Nuclear Medicine and Biology 128, 108877, 2024 | | 2024 |
| Blood-brain barrier permeable antibodies for brain imaging SL van den Broek, S Syvaenen, D Sehlin Nuclear Medicine and Biology 126, 108569, 2023 | | 2023 |
| Aβ targeting ImmunoPET: Brain pharmacokinetics comparison between a brain penetrating and a regular antibody E Schlein, S Lopes van den Broek, T Dallas, KG Andersson, S Syvänen, ... | | 2023 |
| An alpaca-derived nanobody recognizes a unique conserved epitope and retains potent activity against the SARS-CoV-2 omicron variant N Modhiran, SM Lauer, AA Amarilla, P Hewins, SIL van den Broek, ... bioRxiv, 2022.12. 27.521990, 2022 | | 2022 |
| Development and evaluation of an 18F-labeled nanobody to target SARS-CoV-2's spike protein S Lopes van den Broek, R García-Vázquez, IV Andersen, ... Frontiers in Nuclear Medicine 2, 1033697, 2022 | | 2022 |
| Optimized QMA-elution enables direct aliphatic 18F-fluorination of highly reactive tetrazines for pretargeted imaging K Bratteby, U Battisti, RG Vázquez, V Shalgunov, J Jørgensen, L Hvass, ... Nuclear Medicine and Biology 108, S79-S80, 2022 | | 2022 |
